Form D · Other Technology

Remedy Labs, Inc.

San Francisco, CA · CIK 0001654541

Offering snapshot reported Nov 17, 2015 · SEC filing

Reported sold
$1.1M
Offering amount: $1.9M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 2, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$550K$1.1MOct 5, 2015: $500,000.00Oct 5, 2015Nov 17, 2015: $1,100,000.00Nov 17, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$500,000 → $1,100,000
  • Reported investors1 → 10

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 17, 2015Amendment$1,100,000$600,000vs Oct 5, 201510SEC filing
Oct 5, 2015Initial$500,000No comparison1SEC filing

Offering details

Securities
Debt, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-248722
Convertible promissory notes, including the preferred stock and common stock issuable upon conversion thereof

Source: Form D, filed Nov 17, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Victor Echevarria Director, Executive
Marija Ringwelski Executive
John Schulte Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
74 Lynch Street
San Francisco, CA, 94109